Tokyo, Nov. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063510) titled 'A prospective observational study to investigate the effects of pemafinrate on liver function in patients with non-obese Steatotic liver disease and dyslipidemia' on Nov. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Gifu University Hospital
Condition:
Condition - Non- obese metabolic dysfunciton-associated steatotic liver disease(MASLD) with dyslipidemia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effects of pemafibrate, a selective PPAR alpha modulator, on liver function in patients with non-obese MASLD and dyslipidemia.
Basic o...